Inhibition of human red blood cell glutathione reductase by valproic acid.
Glutathione reductase (GR) one of the enzymes of the glutathione redox cycle, plays a salient role in maintaining appropriate cellular levels of reduced glutathione. The enzyme in human red blood cells is inhibited in vitro by the anticonvulsant drug valproic acid (VPA). The inhibition is dose-dependent, reversible, uncompetitive and does not depend on the redox state of the enzyme. VPA also inhibits red blood cell GR activity in children being treated with the drug. The level of serum VPA correlates significantly with the suppression of GR activity.
Cotariu
D
D
Department of Biochemical Pathology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, University of Tel Aviv, Zerifin, Israel.
Evans
S
S
Lahat
E
E
Theitler
J
J
Bistritzer
T
T
Zaidman
J L
JL
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology; D005978:Glutathione / Q000494:pharmacology; D005980:Glutathione Reductase / Q000037:antagonists & inhibitors*; D006801:Humans; D009249:NADP / Q000494:pharmacology; D014635:Valproic Acid / Q000097:blood / Q000494:pharmacology*
D009249:NADP; D014635:Valproic Acid; D005980:Glutathione Reductase; D005978:Glutathione